Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

The OAR Turing-Test Study: A blinded Comparison of expert-Based Organ at Risk Creation and three commercial Auto-Segmentation Solutions (2021) Putz F, Lamrani A, Weissmann T, Mansoorian S, Frey B, Bert C, Fietkau R Conference contribution Detection of Human Cytomegalovirus (HCMV) in monocytic Cells of the peripheral Blood in Glioma Patients during Radio (chemo) Therapy (2021) Bäumler M, Becker I, Frey B, Pohn A, Winkler T, Fietkau R, Gaipl U Conference contribution Low-Dose Radiotherapy is highly effective in the Treatment of painful Finger Polyarthrosis (2021) Weissmann T, Gaipl U, Putz F, Hecht M, Donaubauer AJ, Zhou J, Fietkau R, et al. Conference contribution The Growth of primary and abscopal Tumors as well as their immunological Microenvironment are differently influenced by different Combinations of Radiation and Immunotherapies (2021) Rückert M, Deloch L, Frey B, Fietkau R, Gaipl U Conference contribution Progress Patterns under Radioimmunotherapy - clinical Evaluation of the prospective STICI Study (2021) Schubert P, Schweizer C, Roesch J, Haderlein M, Rutzner S, Semrau S, Donaubauer AJ, et al. Conference contribution Effect of the AMPA Receptor Inhibitor Perampanel in Combination Therapy with ionizing Radiation on Glioblastoma Cells and Fibroblasts (2021) Knabe A, Stritzelberger J, Fietkau R, Distel L Conference contribution Influence of CDK4/6 Inhibitors and Ionizing Radiation on Senescence in Breast Cancer Cells (2021) Quarz L, Jost T, Fietkau R, Distel L Conference contribution In Vitro Examinations of Cell Death Induction and the Immune Phenotype of Cancer Cells Following Radiative-Based Hyperthermia with 915 MHz in Combination with Radiotherapy (2021) Hader M, Streit S, Rosin A, Gerdes T, Wadepohl M, Bekeschus S, Fietkau R, et al. Journal article Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells (2021) Faulhaber EM, Jost T, Symank JA, Scheper J, Burkel F, Fietkau R, Hecht M, Distel L Journal article PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation (2021) Jonuscheit S, Jost T, Gajdošová F, Wrobel M, Hecht M, Fietkau R, Distel L Journal article